Welcome to LookChem.com Sign In|Join Free

CAS

  • or

88609-05-6

Post Buying Request

88609-05-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88609-05-6 Usage

Chemical class

Triazadienes

Explanation

Different sources of media describe the Explanation of 88609-05-6 differently. You can refer to the following data:
1. The compound belongs to the class of triazadienes, which are organic compounds containing a triaza-1,2-dien-2-ium group.
2. The compound has a complex structure consisting of a triaza-1,2-dien-2-ium group, a phenyl ring, a sulfamoyl group, and a pyrimidine ring.
3. The compound contains several functional groups, including a triaza-1,2-dien-2-ium group, a phenyl ring, a sulfamoyl group, and a pyrimidine ring.
4. The chemical structure of the compound suggests that it may have potential applications in the pharmaceutical industry, particularly in the development of drugs targeting specific enzymes or receptors.
5. More research is needed to fully understand the properties and potential uses of this compound, as its current understanding is limited.
6. The compound has a 4-methylpyrimidin-2-yl group attached to the sulfamoyl group and a phenyl ring attached to the triaza-1,2-dien-2-ium group.
7. The triaza-1,2-dien-2-ium group in the compound carries a positive charge of 1+.
8. The compound contains a sulfamoyl group, which is a derivative of a sulfonamide.
9. The phenyl and pyrimidine rings in the compound are aromatic, meaning they have a planar structure and exhibit resonance stabilization.
10. The solubility of the compound in various solvents is not provided in the material and would require further investigation.

Structure

1-4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyltriaza-1,2-dien-2-ium

Functional groups

Triaza-1,2-dien-2-ium, phenyl, sulfamoyl, and pyrimidine

Potential applications

Pharmaceuticals

Research status

Further research necessary

Substituents

4-methylpyrimidin-2-yl and phenyl

Charge

1+ (triaza-1,2-dien-2-ium)

Sulfonamide derivative

Yes

Aromaticity

Present

Solubility

Unknown

Check Digit Verification of cas no

The CAS Registry Mumber 88609-05-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,6,0 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 88609-05:
(7*8)+(6*8)+(5*6)+(4*0)+(3*9)+(2*0)+(1*5)=166
166 % 10 = 6
So 88609-05-6 is a valid CAS Registry Number.

88609-05-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-azido-N-(4-methylpyrimidin-2-yl)benzenesulfonamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88609-05-6 SDS

88609-05-6Upstream product

88609-05-6Downstream Products

88609-05-6Relevant articles and documents

A Click Synthesis, Molecular Docking, Cytotoxicity on Breast Cancer (MDA-MB 231) and Anti-HIV Activities of New 1,4-Disubstituted-1,2,3-Triazole Thymine Derivatives

Al-Hujaj, Hamsa Hussein,Al-Masoudi, Najim Aboud,Faeza, Abdul Kareem Almashal,Jassem, Ahmed Majeed

, p. 360 - 370 (2020/07/02)

Abstract: A new series of 1,4-disubstituted-1,2,3-triazolethymine derivatives (VIa–e) were synthesized and characterized by spectroscopic studies. The in vitro cytotoxic activities of selected compounds against human cancer cell line (MDA-MB 231) were eva

Synthesis and in vitro evaluation of novel galactosyl-triazolo-benzenesulfonamides against Trypanosoma cruzi

Junqueira, Getúlio G.,Carvalho, Marcelo R.,De Andrade, Peterson,Lopes, Carla D.,Carneiro, Zumira A.,Sesti-Costa, Renata,Silva, Jo?o S.,Carvalho, Ivone

, p. 1872 - 1884 (2016/10/12)

The only drugs approved for the treatment of Chagas disease, nifurtimox and benznidazole, present toxic side effects and limited efficacy in the chronic stage of the disease, which highlight the need for new drugs. Amongst the different molecular drug tar

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 88609-05-6